Healthcare technology business Alcidion (ASX: ALC) has sealed a five year agreement with the Hywel Dda University Health Board in Wales for the provision of its Miya Precision platform.
The deal is structured as an annually recurring subscription licence with a total contract value (TCV) of about $5.5 million over the five year term. It also includes an option to extend for a further two years which could lift the TCV to $7.7 million.
It marks Alcidion’s first contract win with a Health Board in Wales and builds on the company’s growing presence in the UK healthcare market.
Improved patient care
As part of the agreement, Alcidion will provide Hywel Dda with its flagship Miya Precision platform designed to enhance clinical decision-making, workflow efficiency, and patient safety by integrating and analysing healthcare data in real-time.
The offering will include the company’s ‘Miya Precision for Patient Flow, Observations and Assessments and Smartpage’ tool used for clinical communications and tasking.
This technology enables clinicians to respond proactively to patient needs by optimising resource allocation, providing clearer insights into vital signs in patients, and streamlining their journeys.
Expanding presence in UK healthcare
The contract win follows a competitive tender process and highlights Alcidion’s growing role in the digitisation of the UK healthcare sector.
The company first entered the UK market in 2018 with the acquisition of leading supplier of healthcare software, Patientrack. Since then, it has grown its footprint by securing multiple contracts with NHS Trusts and Health Boards in the region. In total, Alcidion has 40 clients and serves 132 hospitals in the UK.
Miya Precision will now be integrated across Hywel Dda’s vast network which spans 380,000 people across west Wales and includes four acute hospitals, five community hospitals, two integrated care centres, and a range of primary and community care providers.
Alcidion chief executive officer and managing director, Kate Quirke, commented:
“Introducing Alcidion’s Miya Precision Platform will support Hywel Dda to centralise and digitise essential patient information, optimising multiple inputs of clinical information and patient care metrics across its diverse service network to support improved patient flow and capacity management as well as clinical management of deteriorating patients.”
Growing momentum
Alcidion has acquired multiple healthcare IT companies and expanded its foothold in the UK, Australia, and New Zealand since its listing on the ASX in 2011. Overall, it now services more than 400 hospitals and 87 healthcare organisations with further geographic expansion possibly on the cards.
In Australia, the group recently secured a $3.7 million deal for its Miya Precision platform with Victorian public health service provider Peninsula Health. It also locked in a $4.5 million contract with Northern Adelaide Local Health Network late last year.
Overall, Alcidion delivered $13.1million of new and renewal sales during the second quarter of the 2025 financial year (FY25). Its contracted revenue for the second half of FY25 was reported at $30.8 million, excluding any contribution from its North Cumbria contract or any other new deals which could materialise.